JPMorgan Chase & Co. Takes $3.21 Million Position in Direxion Daily S&P Biotech Bull 3x Shares $LABU

JPMorgan Chase & Co. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 34,270 shares of the company’s stock, valued at approximately $3,208,000.

A number of other large investors also recently added to or reduced their stakes in LABU. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 68.7% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 506 shares of the company’s stock valued at $47,000 after purchasing an additional 206 shares during the period. Qube Research & Technologies Ltd purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter worth approximately $26,000. Headlands Technologies LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the second quarter valued at approximately $69,000. Bank of America Corp DE raised its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% during the third quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock valued at $232,000 after acquiring an additional 1,419 shares during the last quarter. Finally, McGuire Investment Group LLC lifted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 30.2% in the third quarter. McGuire Investment Group LLC now owns 6,547 shares of the company’s stock valued at $613,000 after acquiring an additional 1,519 shares in the last quarter.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

Shares of NYSEARCA:LABU opened at $171.64 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 1 year low of $32.55 and a 1 year high of $198.18. The business’s 50 day moving average price is $162.74 and its 200-day moving average price is $146.81.

Direxion Daily S&P Biotech Bull 3x Shares Company Profile

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.